Market Analysis: Global HIV Diagnosis Market
Global HIV diagnosis market is expected to rise by 2026, registering a healthy CAGR of 10.8% in the forecast period of 2019-2026. This rise in the market can be attributed to the increase in the healthcare expenditure for HIV, government initiatives to curb down HIV and rise in the blood donations and blood transfusions
Market Definition: Global HIV Diagnosis Market
Diagnosis of blood sample to check the presence of Human Immunodeficiency Virus (HIV) in a human body, is defined as HIV diagnosis. Diagnosis of HIV includes several tests such as ELISA Test, Saliva Test, Home Test, Viral Test and Western Test. Rising awareness about the HIV and growth in the number of affected person has increased the demand for latest technology to serve the diagnosis purpose properly. Moreover, home kits for testing for diagnosis of HIV have boost the market.
Market Drivers
- Increase in the healthcare expenditure for HIV may enhance the market
- Government initiatives to curb down HIV would accelerate the growth
- Growth in advance technology might boost the market
- Rise in the blood donations and blood transfusions will drive the market
Market Restraints
- Strict regulations and norms by the governmental bodies might hamper the market
- Huge cost involved in advanced diagnostics can restrict the growth
Segmentation: Global HIV Diagnosis Market
Global HIV Diagnosis Market By Product Type (Consumables, Assay, Kits & Reagents, Other Consumables, Instruments, Software and Services), Test Type (Antibody Tests, CD4 Count, Viral Load, Early Infant and Viral Identification), Application (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Others) – Industry Trends & Forecast to 2026
For more information visit @ https://databridgemarketresearch.com/reports/global-hiv-diagnosis-market
Competitive Analysis:
Global HIV diagnosis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of HIV diagnosis market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Key Market Competitors:
Few of the major market competitors currently working in the global HIV diagnosis market are Siemens, F. Hoffmann-La Roche Ltd, Abbott, Danaher, Thermo Fisher Scientific, Inc., Merck KGaA, BD, Bio-Rad Laboratories, Inc., Hologic, Inc., QIAGEN, bioMerieux SA, AbbVie Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, PointCare, Sysmex Partec GmbH, Apogee Flow Systems Ltd, Sysmex Corporation, ViiV Healthcare group of companies, Gilead Sciences, Inc., Quest Diagnostics Incorporated, Agilent Technologies, Inc., Atomo Diagnostics and others.
Key Developments in the Market:
- In September 2018, Mylan N.V. a global pharmaceutical company became partnered with Atomo Diagnostics. With the partnership, the organizations tried to commercialize the European Conformity mark for their HIV diagnostic test kits in low and middle income countries. The self-testing kits would help consumers in detection of presence of virus in their body within a short duration of time.
- In October 2016, Siemens Healthineers and IBM Watson Health signed a global strategic alliance of five year. The alliance would help Siemens to reach out hospitals and health system in order to provide value based care to patients suffering from HIV.
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.
Contact:
Data Bridge Market Research
+1-888-387-2818
Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide.The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021.Market DynamicsDrivers+ Growing Worldwide Prevalence of HIV/Aids+ Increasing Number of Blood Transfusions and Blood Donations+ Benefits Offered By Point-Of-Care Instruments & Kits+ Increasing Government InitiativesRequest for Free Sample Pages – https://www.marketsandmarkets.com/requestsampleNew.asp?id=66008285AIDS is a major public health concern with a prevalence rate that has increased dramatically in the past two decades.
This increase in the prevalence of HIV, and the subsequent increase in the number of patients suffering from AIDS, has resulted in an increase in the demand for advanced technologies for HIV diagnostics.According to the World Health Organization (WHO), in 2016, around 36 million people were diagnosed with HIV globally, of which 2.1 million were reported to be cases of new HIV infections.
Globally, 1.1 million people died from HIV-related causes in 2015.
According to the CDC, in 2015, more than 1.2 million people in the U.S. were reportedly infected with HIV, and almost 19% of these were not aware about their status.According to Canada’s source for HIV, the CATIE, in 2014, 75,500 Canadians were found to be HIV-infected, and HIV incidence has increased by 9.7% since 2011.
According to the Robert Koch Institute, there were 84,700 individuals with HIV in Germany in 2016 and more than 3,200 new cases of HIV in 2015.
According to AVERT, in 2015, 5.1 million people were living with HIV/AIDS in Asia, of which only 64% population were aware about their HIV status.
